Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2018

Aug 17, 2018

30071_dirs_2018-08-17_a3f55f9e-7d8a-479f-8196-2709e0ede434.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-08-15

Reporting Person: Sodhi Rajwant (President, SaaS Business)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-08-15 ResMed Common Stock A 8512 Acquired 35238 Direct

Footnotes

F1: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on August 15, 2018, when the compensation committee certified that the performance metrics were met.

F2: Includes 169.40 shares of ResMed stock purchased on April 30,2018, through the ResMed Employee Stock Purchase Plan.